UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

Oncogene, 2010-04, Vol.29 (14), p.2013-2023

2010

Volltextzugriff (PDF)

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

The Journal of pathology, 2008-08, Vol.215 (4), p.398-410

2008

Volltextzugriff (PDF)

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

The Journal of pathology, 2006-08, Vol.209 (4), p.445-453

2006

Volltextzugriff (PDF)

Application of Liquid Biopsies in Cancer Targeted Therapy

Clinical pharmacology and therapeutics, 2017-11, Vol.102 (5), p.745-747

2017

Volltextzugriff (PDF)

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

The Journal of pathology, 2008-07, Vol.215 (3), p.231-244

2008

Volltextzugriff (PDF)

Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas

British journal of cancer, 2009-09, Vol.101 (6), p.973-982

2009

Volltextzugriff (PDF)

genomic profile of HER2-amplified breast cancers: the influence of ER status

The Journal of pathology, 2008-12, Vol.216 (4), p.399-407

2008

Volltextzugriff (PDF)

Genomic profile of a secretory breast cancer with an ETV6–NTRK3 duplication

Journal of clinical pathology, 2009-07, Vol.62 (7), p.604-612

2009

Volltextzugriff (PDF)

Comparative analysis of six different antibodies against Her2 including the novel rabbit monoclonal antibody (SP3) and chromogenic in situ hybridisation in breast carcinomas

Journal of clinical pathology, 2008-08, Vol.61 (8), p.934-938

2008

Volltextzugriff (PDF)

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6‘split apart’ probes

Histopathology, 2008-06, Vol.52 (7), p.840-846

2008

Volltextzugriff (PDF)

ESR1 amplification in endometrial carcinomas: hope or hyperbole?

The Journal of pathology, 2008-11, Vol.216 (3), p.271-274

2008

Volltextzugriff (PDF)

Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas

Human molecular genetics, 2013-01, Vol.22 (2), p.226-238

2013

Volltextzugriff (PDF)

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes

Histopathology, 2008-06, Vol.52 (7), p.840-846

2008

Volltextzugriff (PDF)

Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations

Histopathology, 2013-03, Vol.62 (4), p.543-550

2013

Volltextzugriff (PDF)

Use of microarray-based comparative genomic hybridization analysis to identify prognostic subgroups of ovarian clear cell carcinomas

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5020-5020

2010

Volltextzugriff (PDF)

Preclinical evaluation of PARP inhibition as a treatment for endometrioid endometrial carcinomas

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5065-5065

2010

Volltextzugriff (PDF)

P1-06-14: Topoisomerase II alpha (Top2a) Protein Expression Is a Predictor for Response to Anthracycline-Based Chemotherapy (ATC-CT): Is It Due to Gene Amplification, HER2−Coamplification or a Summation of Pathways Leading to This Highly Proliferative Phenotype?

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-06-14

2011

Volltextzugriff (PDF)

MSI-low, a real phenomenon which varies in frequency among cancer types

The Journal of pathology, 2003-11, Vol.201 (3), p.389-394

2003

Volltextzugriff (PDF)

Preclinical evaluation of the PARP-inhibitor olaparib for the treatment of ovarian clear cell cancer

Geburtshilfe und Frauenheilkunde, 2011, Vol.71 (8)

2011

Volltextzugriff (PDF)

Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis

Clinical cancer research, 2007-01, Vol.13 (1), p.90-101

2007

Volltextzugriff (PDF)

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

Breast cancer research : BCR, 2005-01, Vol.7 (6), p.R1028-R1035, Article R1028

2005

Volltextzugriff (PDF)

CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

Nature (London), 2018-07, Vol.559 (7713), p.285-289

2018

Volltextzugriff (PDF)

The Collagen Receptor Endo180 (CD280) Is Expressed on Basal-like Breast Tumor Cells and Promotes Tumor Growth In vivo

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (21), p.10230-10240

2007

Volltextzugriff (PDF)

Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer

Nature medicine, 2011-12, Vol.17 (12), p.1646-1651

2011

Volltextzugriff (PDF)

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer

The Journal of clinical investigation, 2018-10, Vol.128 (10), p.4441-4453

2018

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(108)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(64)
Humans
(58)
Female
(45)
Biological And Medical Sciences
(29)
Medical Sciences
(28)
Oncology
(28)
Breast Neoplasms - Genetics
(22)
Male
(21)
Breast Cancer
(20)
Tumors
(20)
Pathology
(19)
Middle Aged
(17)
Breast Neoplasms - Pathology
(16)
Gynecology. Andrology. Obstetrics
(16)
Technology
(16)
Mammary Gland Diseases
(15)
Cell Line, Tumor
(13)
Investigative Techniques, Diagnostic Techniques
(13)
Adult
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

Application of Liquid Biopsies in Cancer Targeted Therapy

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas

genomic profile of HER2-amplified breast cancers: the influence of ER status

Genomic profile of a secretory breast cancer with an ETV6–NTRK3 duplication

Comparative analysis of six different antibodies against Her2 including the novel rabbit monoclonal antibody (SP3) and chromogenic in situ hybridisation in breast carcinomas

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6‘split apart’ probes

ESR1 amplification in endometrial carcinomas: hope or hyperbole?

Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes

Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations

Use of microarray-based comparative genomic hybridization analysis to identify prognostic subgroups of ovarian clear cell carcinomas

Preclinical evaluation of PARP inhibition as a treatment for endometrioid endometrial carcinomas

P1-06-14: Topoisomerase II alpha (Top2a) Protein Expression Is a Predictor for Response to Anthracycline-Based Chemotherapy (ATC-CT): Is It Due to Gene Amplification, HER2−Coamplification or a Summation of Pathways Leading to This Highly Proliferative Phenotype?

MSI-low, a real phenomenon which varies in frequency among cancer types

Preclinical evaluation of the PARP-inhibitor olaparib for the treatment of ovarian clear cell cancer

Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

The Collagen Receptor Endo180 (CD280) Is Expressed on Basal-like Breast Tumor Cells and Promotes Tumor Growth In vivo

Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer

Suchergebnisse filtern